Gov't to lower age of eligibility for COVID-19 treatment pills from 65 to 60: PM

▲ A pharmacist checks boxes containing Paxlovid, COVID-19 treatment pills developed by U.S. pharmaceutical giant Pfizer Inc., at a drugstore in Seoul on Jan. 14, 2022, as South Korea began to prescribe and administer COVID-19 treatment pills the same day, starting with patients with a weak immune system and those over the age of 65. (Yonhap)

PM-omicron response

Gov't to lower age of eligibility for COVID-19 treatment pills from 65 to 60: PM

SEOUL, Jan. 21 (Yonhap) -- The government will lower the age of eligibility for COVID-19 treatment pills from 65 to 60 to better contain the spread of the omicron variant, Prime Minister Kim Boo-kyum said Friday.

Kim announced the measure during a COVID-19 response meeting held a day after President Moon Jae-in said omicron has become the dominant strain in the country.

The first batch of Pfizer Inc.'s COVID-19 treatment pills arrived in the country last week to be administered first to those with compromised immune systems and those aged 65 and above.

(END)

(C) Yonhap News Agency. All Rights Reserved